15250-m-cuypers

105 PCPCC study protocol 5 50. O’Connor AM. User manual-decision self-efficacy scale. Ottawa: Ottawa Hospital Research Institute (OHIR); 1995. https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_ Decision_SelfEfficacy.pdf. Accessed 1 October 2014. 51. Orom H, Penner LA, West BT, Downs TM, Rayford W, Underwood W. Personality predicts prostate cancer treatment decision‐making difficulty and satisfaction. Psychooncology. 2009;18(3):290-9. 52. Wong F, Stewart DE, Dancey J, Meana M, McAndrews MP, Bunston T et al. Men with prostate cancer: influence of psychological factors on informational needs and decision-making. J Psychosom Res. 2000;49(1):13-9. 53. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. 54. Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O'shea N, Scher H et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX–PC). Psychosomatics. 2006;47(4):340-7. 55. Van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot M-L. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer. Qual Life Res. 2009;18(8):1061-6. 56. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994;67(6):1063. 57. Rammstedt B, John OP. Measuring personality in one minute or less: A 10-item short version of the Big Five Inventory in English and German. J Res Pers. 2007;41(1):203-12. 58. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients’ desire for autonomy. J Gen Intern Med. 1989;4(1):23-30. 59. Schwartz B, Ward A, Monterosso J, Lyubomirsky S, White K, Lehman DR. Maximizing versus satisficing: happiness is a matter of choice. J Pers Soc Psychol. 2002;83(5):1178. 60. Fleuren MA, Paulussen TG, Van Dommelen P, Van Buuren S. Towards a measurement instrument for determinants of innovations. Int J Qual Health Care. 2014;26(5):501-10. 61. Naylor CD, Llewellyn-Thomas HA. Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol. 1994;47(7):787-95. 62. Campbell MK, Fayers PM, Grimshaw JM. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clin Trials. 2005;2(2):99-107. 63. Bell ML, McKenzie JE. Designing psycho‐oncology randomised trials and cluster randomised trials: variance components and intra‐cluster correlation of commonly used psychosocial measures. Psycho‐Oncology. 2013;22(8):1738-47. 64. Schofield P, Lotti-Jam, K., Gough, K., Dudgeon P, Bergin R, Crellin W, et al. A nurse-led group consultation intervention to reduce psychological morbidity and unmet needs in men with prostate cancer during radiotherapy: a randomised controlled trial. New York City, USA: MASCC/ISOO International Symposium on Supportive Care in Cancer; 2012: 145-145.